Evaluating the percentage of lymphoid CD8+ T cells expressing the T cell exhaustion marker PD-1 or the percentage of CD68+ cells expressing a high level of PD-L1 may serve as a better independent prognostic indicator for PDAC than assessing the density of tumor-infiltrating cells, which involves using a single marker to indicate an immune cell. This evidence concerns the gene CD274 and neoplasm.